ChemicalBook > CAS DataBase List > Dihydroxythiobinupharidine

Dihydroxythiobinupharidine

Product Name
Dihydroxythiobinupharidine
CAS No.
30343-70-5
Chemical Name
Dihydroxythiobinupharidine
Synonyms
Dihydroxythiobinupharidine;6,6′-Dihydroxythiobinupharidine;6,6'-Dihydroxythiobinupharidine >=95% (HPLC);Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]-4,4''-diol, 6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-, (2'S,3''S,4S,4''R,6S,6''S,9R,9''R,9aS,9''aS)-
CBNumber
CB81120248
Molecular Formula
C30H42N2O4S
Formula Weight
526.73
MOL File
30343-70-5.mol
More
Less

Dihydroxythiobinupharidine Property

Boiling point:
667.3±55.0 °C(Predicted)
Density 
1.30±0.1 g/cm3(Predicted)
storage temp. 
-20°C
form 
powder
pka
13.42±0.70(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SMB00609
Product name
6,6′-Dihydroxythiobinupharidine
Purity
≥95% (HPLC)
Packaging
1mg
Price
$545
Updated
2024/03/01
More
Less

Dihydroxythiobinupharidine Chemical Properties,Usage,Production

General Description

6,6′-Dihydroxythiobinupharidine is an active compound found in Nuphar lutea extract. It is a dimeric sesquiterpene thioalkaloid which presents multiple activities.

Biochem/physiol Actions

6,6′-Dihydroxythiobinupharidine inhibits NFκB activation, leading to an induction of apoptosis via cleavage of procaspase-9 and poly (ADP-ribose) polymerase (PARP). It was also found to act synergistically with cytotoxic drugs such as cisplatin and etoposide, enabling their cytotoxic effect at lower concentrations. 6,6′-Dihydroxythiobinupharidine was found to have cytotoxic activity at a concentration of ~10 μM on human leukemia cells (U937), mouse melanoma cells (B16F10), and human fibroblasts (HT1080).In addition, Nuphar lutea extract was effective against both Leishmania promastigote and amastigote forms (IC50?=?2?±?0.12?μg/mL; ID50?=?0.65?±?0.023?μg/mL; LD50?=?2.1?±?0.096?μg/mL, STI?=?3.23). A synergistic antileishmanial activity was demonstrated with the antileishmanial drug, paromomycin.Recently 6,6′-dihydroxythiobinupharidine was found to be active against MRSA and VRE strains with an MIC of 1-4?μg/mL. Inhibition of DNA topoisomerase?IV but not DNA gyrase in S.?aureus was suggested as the mechanism of action. 6,6′-Dihydroxythiobinupharidine was also shown to promote neutrophil effector bactericidal functions.

Dihydroxythiobinupharidine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Dihydroxythiobinupharidine Suppliers

Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing@energy-chemical.com
Country
China
ProdList
44918
Advantage
58

30343-70-5, DihydroxythiobinupharidineRelated Search:


  • Dihydroxythiobinupharidine
  • 6,6′-Dihydroxythiobinupharidine
  • Dispiro[2H-quinolizine-3(4H),2'(3'H)-thiophene-4'(5'H),3''(4''H)-[2H]quinolizine]-4,4''-diol, 6,6''-di-3-furanyldodecahydro-9,9''-dimethyl-, (2'S,3''S,4S,4''R,6S,6''S,9R,9''R,9aS,9''aS)-
  • 6,6'-Dihydroxythiobinupharidine >=95% (HPLC)
  • 30343-70-5
  • C30H42N2O4S